PASSAGE BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
PASSAGE BIO, INC. (PASG) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$105.00 thousand for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-03
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$158.00K.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $53.00K, a 92.52% decline year-over-year.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.03M.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $235.00K.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$3.84M.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.74M.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$1.84M.
- PASSAGE BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was -$1.87M, a 118.61% decline from fiscal 2019.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$158.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | -$105.00K S-4/A · filed 2026-09-03 | -$1.14M derived: sum of 3 quarters · filed 2026-09-03 | -$904.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-03-31 | $53.00K S-4 · filed 2026-07-21 | -$981.00K derived: sum of 2 quarters · filed 2026-09-03 | -$746.00K derived: sum of 3 quarters · filed 2026-09-03 | -$884.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | -$1.03M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | -$799.00K derived: sum of 2 quarters · filed 2026-09-03 | -$937.00K derived: sum of 3 quarters · filed 2026-09-03 | -$228.00K S-4/A · filed 2026-09-03 |
| 2025-09-30 | $235.00K derived: 10-Q 9 month − S-4/A 6 month · filed 2025-11-10 | $97.00K derived: sum of 2 quarters · filed 2026-09-03 | $806.00K 10-Q · filed 2025-11-10 | $434.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | -$138.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-09-03 | $571.00K S-4/A · filed 2026-09-03 | $199.00K derived: sum of 3 quarters · filed 2026-09-03 | -$41.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-03-31 | $709.00K S-4 · filed 2026-07-21 | $337.00K derived: sum of 2 quarters · filed 2026-09-03 | $97.00K derived: sum of 3 quarters · filed 2026-09-03 | -$636.00K derived: sum of 4 quarters · filed 2026-09-03 |
| 2024-12-31 | -$372.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | -$612.00K derived: sum of 2 quarters · filed 2026-09-03 | -$1.34M derived: sum of 3 quarters · filed 2026-09-03 | -$255.00K S-4/A · filed 2026-09-03 |
| 2024-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$973.00K derived: sum of 2 quarters · filed 2025-11-10 | $117.00K 10-Q · filed 2025-11-10 | -$242.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$733.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $357.00K 10-Q · filed 2025-08-12 | -$2.00K derived: sum of 3 quarters · filed 2025-08-12 | $50.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.09M 10-Q · filed 2025-05-13 | $731.00K derived: sum of 2 quarters · filed 2025-05-13 | $783.00K derived: sum of 3 quarters · filed 2025-05-13 | $328.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$307.00K derived: sum of 2 quarters · filed 2025-03-04 | -$762.00K derived: sum of 3 quarters · filed 2025-03-04 | -$3.84M 10-K · filed 2025-03-04 |
| 2023-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$403.00K derived: sum of 2 quarters · filed 2024-11-13 | -$3.48M 10-Q · filed 2024-11-13 | -$4.51M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$455.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.53M 10-Q · filed 2024-08-08 | -$4.57M derived: sum of 3 quarters · filed 2024-08-08 | -$5.87M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$3.08M 10-Q · filed 2024-05-14 | -$4.11M derived: sum of 2 quarters · filed 2024-05-14 | -$5.42M derived: sum of 3 quarters · filed 2024-05-14 | -$6.44M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | -$2.34M derived: sum of 2 quarters · filed 2024-03-04 | -$3.36M derived: sum of 3 quarters · filed 2024-03-04 | -$2.74M 10-K · filed 2024-03-04 |
| 2022-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.33M derived: sum of 2 quarters · filed 2023-11-13 | -$1.70M 10-Q · filed 2023-11-13 | -$3.61M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$394.00K 10-Q · filed 2023-08-07 | -$2.30M derived: sum of 3 quarters · filed 2023-08-07 | -$3.53M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $624.00K 10-Q · filed 2023-05-11 | -$1.28M derived: sum of 2 quarters · filed 2023-05-11 | -$2.52M derived: sum of 3 quarters · filed 2023-05-11 | -$2.58M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$3.14M derived: sum of 2 quarters · filed 2023-03-06 | -$3.21M derived: sum of 3 quarters · filed 2023-03-06 | -$1.84M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.30M derived: sum of 2 quarters · filed 2022-11-10 | $66.00K 10-Q · filed 2022-11-10 | -$678.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.30M 10-Q · filed 2022-08-04 | $553.00K derived: sum of 3 quarters · filed 2022-08-04 | -$377.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.37M 10-Q · filed 2022-05-16 | $622.00K derived: sum of 2 quarters · filed 2022-05-16 | -$308.00K derived: sum of 3 quarters · filed 2022-05-16 | -$1.48M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$744.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$1.67M derived: sum of 2 quarters · filed 2022-03-03 | -$2.85M derived: sum of 3 quarters · filed 2022-03-03 | -$1.87M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$930.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$2.10M derived: sum of 2 quarters · filed 2021-11-04 | -$1.13M 10-Q · filed 2021-11-04 | -$1.08M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$197.00K 10-Q · filed 2021-08-05 | -$155.00K derived: sum of 3 quarters · filed 2021-08-05 | $9.90M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $978.00K 10-Q · filed 2021-05-05 | $1.02M derived: sum of 2 quarters · filed 2021-05-05 | $11.08M derived: sum of 3 quarters · filed 2021-05-05 | $11.06M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $10.10M derived: sum of 2 quarters · filed 2021-03-03 | $10.08M derived: sum of 3 quarters · filed 2021-03-03 | $10.05M 10-K · filed 2021-03-03 |
| 2019-09-30 | $10.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $10.04M derived: sum of 2 quarters · filed 2020-11-10 | $10.01M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$46.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$31.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |